3M Company enters the back half of June with a fresh bearish analyst call landing on the same day short sellers are quietly rebuilding positions — a small but notable tension for a stock that has already rallied 9% in a month.
Bernstein kicked off coverage this morning with an Underperform rating and a $131 target, roughly 16% below Tuesday's close of $156.39. That's the headline mover this week. The call lands into a mixed Street backdrop: Wells Fargo remains Overweight with a $165 target after lifting it post-Q1, and Barclays holds Overweight at $185, while RBC Capital sits on the opposite side with an Underperform and a $133 target. Citi is in the middle at Neutral. The split reflects the genuine debate over 3M's restructuring trajectory — bulls point to four consecutive quarters of consumer-segment growth, adjusted operating margins hitting 24.4% in Q3 2025, and an organic sales print of 3.2% that beat consensus; bears flag a 2.2% consumer-revenue shortfall, slowing Chinese industrial demand, and lingering PFAS litigation uncertainty. The mean analyst price target of roughly $175 sits well above the current price, but the addition of two sub-$135 Underperform targets pulls on the lower end and is worth tracking. Valuation multiples have drifted higher with the stock — the P/E has expanded by 1.3 turns over the past month to 17.3x, and EV/EBITDA has moved to 11.5x, creeping higher as the price has run.
Short interest, while low in absolute terms, is accelerating faster than the price. At 1.84% of the free float, the headline number is not alarming. But shorts rose 16% over the past week and are up 27% over the past month — the fastest rate of accumulation in the data window. The daily estimate climbed from roughly 8.5 million shares on June 8 to 9.8 million by June 9, a single-session jump of 14.5%. That pace of rebuild, even from a low base, is unusual for a Dow component. Cost to borrow has ticked up sharply on the week — now at 0.40%, a 26% weekly rise — though in absolute terms it remains trivially cheap. Borrowing 3M shares is easy: availability is essentially uncapped, with over 519 million shares available to lend. There is no squeeze pressure here. This looks less like a conviction short and more like incremental hedging activity around the Bernstein initiation and the upcoming July 17 earnings date.
Options positioning tells a slightly more constructive story. The put/call ratio dropped to 1.18 on Tuesday — meaningfully below its 20-day average of 1.29 and running about 1.3 standard deviations lighter on the defensive side than recent norms. That's a modest but real shift toward call exposure at a moment when the short book is growing. The 52-week PCR range runs from 0.40 to 1.66, so Tuesday's reading is comfortably mid-range. The contrast between a rebuilding short book and a relatively unbothered options market is the interesting tension here: shorts are adding, but hedgers are not rushing to buy protection.
Institutional ownership remains heavily concentrated in passive and large active managers. BlackRock holds 8.2% after adding 3.5 million shares in the most recent reported period; JP Morgan Asset Management holds 7.6% after adding 1.1 million. D.E. Shaw built a new position of 5.3 million shares as of March 31, a move worth watching given the firm's tendency to express more directional views than pure passive allocators. On the insider side, the CEO and CTO both sold shares on May 1 at $142.50 — well below the current price — alongside award grants, suggesting these were plan-driven rather than discretionary. Net insider activity over 90 days is technically positive at roughly $13.7 million, but that figure is largely award-driven rather than open-market buying.
The next earnings release is July 17. The past two prints produced opposite reactions: Q1 2026 results in May drove a 2.6% one-day gain; Q4 2025 results in April dropped the stock 3.7%. With the Bernstein Underperform now on the tape at $131 and the short book building, how management frames the China industrial slowdown and PFAS liability trajectory will be the key variables to watch going into that release.
See the live data behind this article on ORTEX.
Open MMM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
